US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LB Pharmaceuticals

30.36

-1.0550-3.36%

Volume:16.59K

Turnover:508.16K

Market Cap:868.33M

PE:-11.70

High:30.95

Open:30.84

Low:30.10

Close:31.41

52wk High:33.47

52wk Low:13.36

Shares:28.61M

Float Shares:19.00M

Volume Ratio:0.55

T/O Rate:0.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5941

EPS(LYR):-3.1329

ROE:-20.02%

ROA:-13.68%

PB:2.29

PE(LYR):-9.69

Loading ...

Overview Company News Filings

LB Pharmaceuticals reports Q1 EPS (67c), consensus (67c)

LB Pharmaceuticals Q1 EPS $(0.67) Beats $(0.75) Estimate

LB Pharmaceuticals Q1 FY26 net loss widens to $19.1 million

Press Release: LB Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update

This LB Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

LB Pharmaceuticals Initiated at Buy by HC Wainwright & Co.

HC Wainwright Initiates Coverage on LB Pharmaceuticals With Buy Rating, $45 Price Target

MT Newswires Live

LB Pharmaceuticals initiated with a Buy at H.C. Wainwright

LB Pharmaceuticals announces annual shareholder meeting

Analysts Offer Insights on Healthcare Companies: LB Pharmaceuticals, Inc. (LBRX) and West Pharmaceutical Services (WST)

Piper Sandler Reaffirms Their Buy Rating on LB Pharmaceuticals, Inc. (LBRX)

LB Pharma publishes positive Phase 2 LB-102 schizophrenia trial results in JAMA Psychiatry

Lb Pharmaceuticals Announces Publication in Jama Psychiatry of Results From Phase 2 Nova-1 Trial of Lb-102 in Schizophrenia

THOMSON REUTERS

LB-102 Bipolar Depression Trial Moves Forward: What LBRX Investors Should Know

LB Pharmaceuticals, Inc. (LBRX) Gets a Buy from Roth MKM

LB Pharmaceuticals Initiated at Buy by Craig-Hallum

LB Pharmaceuticals initiated with a Buy at Craig-Hallum

LB Pharmaceuticals CEO to present at Needham Virtual Healthcare Conference

LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference

LB Pharmaceuticals files to sell 4.78M shares of common stock for holders

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LBRX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LBRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LBRX\",,,,,undefined,":{"symbol":"LBRX","market":"US","secType":"STK","nameCN":"LB Pharmaceuticals","latestPrice":30.355,"timestamp":1778858846589,"preClose":31.41,"halted":0,"volume":16585,"delay":0,"changeRate":-0.03358802929003501,"floatShares":19000000,"shares":28605700,"eps":-2.594121,"marketStatus":"Trading","change":-1.055,"latestTime":"05-15 11:27:27 EDT","open":30.84,"high":30.95,"low":30.1,"amount":508157.55039499997,"amplitude":0.027061,"askPrice":30.59,"askSize":101,"bidPrice":30.12,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-2.594121,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1778875200000},"marketStatusCode":2,"adr":0,"listingDate":1757563200000,"exchange":"NASDAQ","adjPreClose":31.41,"postHourTrading":{"tag":"盘后","latestPrice":31.41,"preClose":31.41,"latestTime":"16:10 EDT","volume":290,"amount":9108.9,"timestamp":1778789404375,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.554926},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LBRX\",,,,,undefined,":{"symbol":"LBRX","floatShares":19000000,"roa":"-13.68%","roe":"-20.02%","lyrEps":-3.132945,"volumeRatio":0.554926,"shares":28605700,"dividePrice":0,"high":30.95,"amplitude":0.027061,"preClose":31.41,"low":30.1,"week52Low":13.36,"pbRate":"2.29","week52High":33.47,"institutionHeld":0,"latestPrice":30.355,"committee":0.328904,"eps":-2.594121,"divideRate":0,"volume":16585,"delay":0,"ttmEps":-2.594121,"open":30.84,"prevYearClose":22.26,"prevWeekClose":31.97,"prevMonthClose":31.71,"prevQuarterClose":24.66,"fiveDayClose":31.97,"twentyDayClose":30.52,"sixtyDayClose":24.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LBRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-12","symbol":"LBRX","fiscalQuarterEnding":"2026/03","expectedEps":-0.75,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.67},{"market":"US","date":"2026-03-26","symbol":"LBRX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LBRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LBRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1777348800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LBRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LBRX","date":"2026-05-13","current":-12.108148,"percent":0.678571,"low":-37.407457,"twenty":-32.316764,"median":-26.867851,"eighty":-12.552639,"high":-0.410019,"avg":-24.894735,"sd":8.51847,"marketCap":892704176},"quantilePoints":[{"date":"2025-09-12","current":-13.187639,"twenty":-10.632115,"median":-6.798829,"eighty":-2.965543,"marketCap":388099031},{"date":"2025-09-19","current":-12.217088,"twenty":-12.798201,"median":-12.438246,"eighty":-12.070666,"marketCap":359536683},{"date":"2025-09-26","current":-11.40109,"twenty":-12.682283,"median":-12.163705,"eighty":-11.408716,"marketCap":335522685},{"date":"2025-10-03","current":-11.790024,"twenty":-12.394014,"median":-12.03406,"eighty":-11.475827,"marketCap":346968609},{"date":"2025-10-10","current":-11.927294,"twenty":-12.217088,"median":-11.973051,"eighty":-11.471251,"marketCap":351008347},{"date":"2025-10-17","current":-12.506882,"twenty":-12.401641,"median":-12.018808,"eighty":-11.491079,"marketCap":368065019},{"date":"2025-10-24","current":-12.079817,"twenty":-12.247593,"median":-12.026434,"eighty":-11.561239,"marketCap":355496945},{"date":"2025-10-31","current":-12.415368,"twenty":-12.43367,"median":-12.041687,"eighty":-11.652753,"marketCap":365371860},{"date":"2025-11-07","current":-18.511527,"twenty":-12.493155,"median":-12.14464,"eighty":-11.774771,"marketCap":348090759},{"date":"2025-11-14","current":-20.046619,"twenty":-12.715838,"median":-12.201836,"eighty":-11.777822,"marketCap":376956619},{"date":"2025-11-21","current":-21.244034,"twenty":-16.587413,"median":-12.217088,"eighty":-11.811377,"marketCap":399472820},{"date":"2025-11-28","current":-23.934856,"twenty":-18.511527,"median":-12.278098,"eighty":-11.89679,"marketCap":450071024},{"date":"2025-12-05","current":-25.899155,"twenty":-20.625145,"median":-12.354359,"eighty":-11.912042,"marketCap":487007713},{"date":"2025-12-12","current":-27.217658,"twenty":-21.714928,"median":-12.472564,"eighty":-11.927294,"marketCap":511800833},{"date":"2025-12-19","current":-26.50459,"twenty":-23.934856,"median":-12.598395,"eighty":-11.934921,"marketCap":498392309},{"date":"2025-12-26","current":-29.599034,"twenty":-25.317938,"median":-12.735666,"eighty":-11.971526,"marketCap":556580244},{"date":"2026-01-02","current":-29.948841,"twenty":-26.033696,"median":-12.811928,"eighty":-12.003556,"marketCap":563158010},{"date":"2026-01-09","current":-27.984542,"twenty":-26.736001,"median":-17.717835,"eighty":-12.027959,"marketCap":526221321},{"date":"2026-01-16","current":-28.76488,"twenty":-26.943194,"median":-18.511527,"eighty":-12.038636,"marketCap":540894800},{"date":"2026-01-23","current":-31.724783,"twenty":-27.597063,"median":-20.046619,"eighty":-12.056939,"marketCap":596552825},{"date":"2026-01-30","current":-28.482344,"twenty":-28.30475,"median":-20.93459,"eighty":-12.092019,"marketCap":535581989},{"date":"2026-02-06","current":-32.101498,"twenty":-28.673392,"median":-21.418938,"eighty":-12.137776,"marketCap":603636573},{"date":"2026-02-13","current":-32.760749,"twenty":-28.899421,"median":-22.367452,"eighty":-12.188109,"marketCap":616033133},{"date":"2026-02-20","current":-32.558938,"twenty":-29.179266,"median":-23.692682,"eighty":-12.201836,"marketCap":612238268},{"date":"2026-02-27","current":-32.5993,"twenty":-29.599034,"median":-24.876643,"eighty":-12.203361,"marketCap":612997241},{"date":"2026-03-06","current":-31.684421,"twenty":-30.30403,"median":-25.616619,"eighty":-12.210987,"marketCap":595793852},{"date":"2026-03-13","current":-33.554542,"twenty":-31.627914,"median":-25.899155,"eighty":-12.217088,"marketCap":630959603},{"date":"2026-03-20","current":-32.276402,"twenty":-31.988483,"median":-26.370049,"eighty":-12.224714,"marketCap":606925456},{"date":"2026-03-27","current":-24.621582,"twenty":-31.988483,"median":-26.625677,"eighty":-12.26437,"marketCap":620586972},{"date":"2026-04-02","current":-24.902627,"twenty":-31.966957,"median":-26.235508,"eighty":-12.300976,"marketCap":627670720},{"date":"2026-04-10","current":-26.388153,"twenty":-31.886233,"median":-26.156251,"eighty":-12.33148,"marketCap":665113391},{"date":"2026-04-17","current":-28.385582,"twenty":-31.84587,"median":-26.235508,"eighty":-12.354359,"marketCap":715458604},{"date":"2026-04-24","current":-35.011617,"twenty":-31.993865,"median":-26.565134,"eighty":-12.415368,"marketCap":882467800},{"date":"2026-05-01","current":-36.076352,"twenty":-32.168769,"median":-26.669198,"eighty":-12.438246,"marketCap":909304449},{"date":"2026-05-08","current":-36.38353,"twenty":-32.30331,"median":-26.814034,"eighty":-12.506882,"marketCap":917046871},{"date":"2026-05-13","current":-22.917469,"twenty":-32.316764,"median":-26.867851,"eighty":-12.552639,"marketCap":892704176}],"updateTime":1778826068292},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LBRX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635252212","title":"LB Pharmaceuticals reports Q1 EPS (67c), consensus (67c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635252212","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635252212?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:46","pubTimestamp":1778622391,"startTime":"0","endTime":"0","summary":"“With multiple clinical trials ongoing, our focus is on execution to support several clinical readouts over the next three years that have the pote...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-reports-q1-eps-67c-consensus-67c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-reports-q1-eps-67c-consensus-67c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LBRX","LB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635223322","title":"LB Pharmaceuticals Q1 EPS $(0.67) Beats $(0.75) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635223322","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635223322?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:06","pubTimestamp":1778620008,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals (NASDAQ:LBRX) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(0.75) by 10.67 percent. This is a 95.47 percent increase over losses of $(14.79) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52508924/lb-pharmaceuticals-q1-eps-0-67-beats-0-75-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LBRX","LB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635247446","title":"LB Pharmaceuticals Q1 FY26 net loss widens to $19.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635247446","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635247446?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:10","pubTimestamp":1778616625,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals posted a net loss of $19.1 million for first-quarter 2026, widening from $5.3 million a year earlier, as operating loss deepened to $22.1 million from $6.43 million.R&D expense climbed to $14.6 million from $3.4 million, due to higher clinical trial costs tied to LB-102 studies in bipolar 1 depression and acute schizophrenia, alongside higher production and personnel spending.G&A expense rose to $7.5 million from $3 million, driven by higher headcount, stock-based compensation, and professional fees.Cash, cash equivalents, and marketable securities increased to $365.6 million as of March 31, 2026, with runway expected into Q2 2029.Initiated Phase 3 NOVA-2 in schizophrenia with topline data expected in second-half 2027, started Phase 2 ILLUMINATE-1 in bipolar 1 depression with data expected in Q1 2028, and reiterated plans to begin a Phase 2 adjunctive MDD trial in early 2027 with data expected in first-half 2029.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL8PqpLN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","BK4588","SG9999014005.SGD","NDAQ","LBRX","BK4585","IE00BKPKM429.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4007","LU2095319765.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014021.USD","BK4112","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635237247","title":"Press Release: LB Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635237247","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635237247?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616300,"startTime":"0","endTime":"0","summary":"Initiated two late-stage clinical trials of LB-102: the pivotal Phase 3 NOVA-2 trial in schizophrenia and the Phase 2 ILLUMINATE-1 trial in bipolar depression. Published results from the Phase 2 NOVA-1 trial of LB-102 in schizophrenia in The Journal of the American Medical Association  Psychiatry. Expanded pipeline following $100 million private placement with plans to initiate a Phase 2 trial of LB-102 in adjunctive treatment of major depressive disorder  in early 2027. Cash, cash equivalents, and marketable securities of $365.6 million as of March 31, 2026 expected to fund operations into Q2 2029, through multiple clinical milestones","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LB","BK4233","BK4213","BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630399509","title":"This LB Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=2630399509","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630399509?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:08","pubTimestamp":1777291680,"startTime":"0","endTime":"0","summary":"Top Wall Street analysts changed outlook on top names. See analyst rating changes, including upgrades/downgrades/initiations, on Benzinga.","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/27/Morgan-Stanley-strategist-Denny-Galindo-.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/27/Morgan-Stanley-strategist-Denny-Galindo-.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/analyst-stock-ratings/initiation/26/04/52058957/this-lb-pharmaceuticals-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/initiation/26/04/52058957/this-lb-pharmaceuticals-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BLSG","BK4007","BK4233","LBRX","BK4213","BK4112","BLSX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630395876","title":"LB Pharmaceuticals Initiated at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2630395876","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630395876?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:26","pubTimestamp":1777289160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LBRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 27, 2026 07:26 ET (11:26 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LB","BK4007","LBRX","BK4213","BK4233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630288393","title":"HC Wainwright Initiates Coverage on LB Pharmaceuticals With Buy Rating, $45 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2630288393","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630288393?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:21","pubTimestamp":1777288907,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals Inc (LBRX) has an average rating of Buy and mean price target of $44, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LBRX","LB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630367577","title":"LB Pharmaceuticals initiated with a Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2630367577","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630367577?lang=en_us&edition=fundamental","pubTime":"2026-04-27 18:17","pubTimestamp":1777285037,"startTime":"0","endTime":"0","summary":"H.C. Wainwright initiated coverage of LB Pharmaceuticals (LBRX) with a Buy rating and $45 price target The company is focused on the neuropsychiatr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-initiated-with-a-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-initiated-with-a-buy-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LBRX","BK4233","LB","BK4007","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629319868","title":"LB Pharmaceuticals announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629319868","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629319868?lang=en_us&edition=fundamental","pubTime":"2026-04-24 04:12","pubTimestamp":1776975145,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals scheduled annual shareholder meeting for June 3, 2026 via virtual webcast.Shareholders set to vote on election of three Class I directors, with terms running to 2029 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LB Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL3l8Q0k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629859974","title":"Analysts Offer Insights on Healthcare Companies: LB Pharmaceuticals, Inc. (LBRX) and West Pharmaceutical Services (WST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629859974","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629859974?lang=en_us&edition=fundamental","pubTime":"2026-04-24 00:10","pubTimestamp":1776960640,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on LB Pharmaceuticals, Inc. (LBRX) and West Pharmaceuti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-lb-pharmaceuticals-inc-lbrx-and-west-pharmaceutical-services-wst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-lb-pharmaceuticals-inc-lbrx-and-west-pharmaceutical-services-wst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4504","HCSG","IE00BFXG0V08.USD","LU0128526141.USD","BK4007","BK4588","LU0345774631.USD","IE00BYQQ9H92.USD","BK4585","XLV","LU0029874061.USD","LABU","BK4121","LB","WST","BK4233","BK4581","XBI","LU0106261612.USD","BK4567","IE00B64QTZ34.USD","LU0345774391.USD","BK4213","BK4137","LBRX","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629582836","title":"Piper Sandler Reaffirms Their Buy Rating on LB Pharmaceuticals, Inc. (LBRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629582836","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629582836?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:40","pubTimestamp":1776944426,"startTime":"0","endTime":"0","summary":"In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on LB Pharmaceuticals, Inc., with a price target of $78.00. R...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-reaffirms-their-buy-rating-on-lb-pharmaceuticals-inc-lbrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-reaffirms-their-buy-rating-on-lb-pharmaceuticals-inc-lbrx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LB","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629027227","title":"LB Pharma publishes positive Phase 2 LB-102 schizophrenia trial results in JAMA Psychiatry","url":"https://stock-news.laohu8.com/highlight/detail?id=2629027227","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629027227?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:07","pubTimestamp":1776888438,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals published Phase 2 NOVA-1 trial results for once-daily oral LB-102 in JAMA Psychiatry; findings were first presented in early 2025.Trial showed LB-102 improved symptoms versus placebo, with rapid onset and sustained benefit through study end.Safety profile was described as favorable, with low rates of movement-related side effects, minimal sedation, and limited gastrointestinal issues.Pivotal Phase 3 NOVA-2 trial in acute schizophrenia is ongoing; topline results expected in second half of 2027.NOVA-2 is designed to enroll about 460 patients across 25 US sites, positioning LB-102 for a pre-NDA FDA meeting if results are positive.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL2FTTFF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BKPKM429.USD","BK4585","LU2095319765.USD","BK4112","BK4007","SG9999014039.USD","IE00B64PRP62.GBP","BK4588","LU0314104364.USD","LU2210150020.SGD","NDAQ","LBRX","SG9999014021.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629027128","title":"Lb Pharmaceuticals Announces Publication in Jama Psychiatry of Results From Phase 2 Nova-1 Trial of Lb-102 in Schizophrenia","url":"https://stock-news.laohu8.com/highlight/detail?id=2629027128","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629027128?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:05","pubTimestamp":1776888302,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nTUABNDCBQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628551217","title":"LB-102 Bipolar Depression Trial Moves Forward: What LBRX Investors Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2628551217","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628551217?lang=en_us&edition=fundamental","pubTime":"2026-04-19 00:32","pubTimestamp":1776529926,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals, Inc. ($LBRX) announced an update on their ongoing clinical study. This Phase II clinical study, titled “A Randomized, Double Bl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lb-102-bipolar-depression-trial-moves-forward-what-lbrx-investors-should-know?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lb-102-bipolar-depression-trial-moves-forward-what-lbrx-investors-should-know?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LBRX","BK4233","BK4211","BK4007","LB","BK4213","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627422927","title":"LB Pharmaceuticals, Inc. (LBRX) Gets a Buy from Roth MKM","url":"https://stock-news.laohu8.com/highlight/detail?id=2627422927","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627422927?lang=en_us&edition=fundamental","pubTime":"2026-04-15 05:18","pubTimestamp":1776201533,"startTime":"0","endTime":"0","summary":"Roth MKM analyst Boobalan Pachaiyappan reiterated a Buy rating on LB Pharmaceuticals, Inc. today and set a price target of $31.00. According to Tip...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lb-pharmaceuticals-inc-lbrx-gets-a-buy-from-roth-mkm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lb-pharmaceuticals-inc-lbrx-gets-a-buy-from-roth-mkm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4233","LBRX","LB","BK4007","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626902112","title":"LB Pharmaceuticals Initiated at Buy by Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2626902112","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626902112?lang=en_us&edition=fundamental","pubTime":"2026-04-11 02:04","pubTimestamp":1775844240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LBRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 10, 2026 14:04 ET (18:04 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4233","BK4007","LBRX","LB","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626419263","title":"LB Pharmaceuticals initiated with a Buy at Craig-Hallum","url":"https://stock-news.laohu8.com/highlight/detail?id=2626419263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626419263?lang=en_us&edition=fundamental","pubTime":"2026-04-10 19:33","pubTimestamp":1775820835,"startTime":"0","endTime":"0","summary":"Craig-Hallum initiated coverage of LB Pharmaceuticals (LBRX) with a Buy rating and $36 price target Published first on TheFly – the ultimate source...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-initiated-with-a-buy-at-craig-hallum-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-initiated-with-a-buy-at-craig-hallum-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LBRX","BK4213","BK4007","BK4233","LB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626523130","title":"LB Pharmaceuticals CEO to present at Needham Virtual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2626523130","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626523130?lang=en_us&edition=fundamental","pubTime":"2026-04-10 04:09","pubTimestamp":1775765371,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals CEO Heather Turner will present at Needham 25th Annual Virtual Healthcare Conference on April 16, 2026 at 11:45 a.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL2DPBLX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210149790.SGD","NDAQ","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014021.USD","BK4585","LU2095319765.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4007","BK4588","SG9999014039.USD","SG9999014013.SGD","LBRX","IE00BN0W2V16.EUR","LU2210150020.SGD","BK4112","IE00BN0W2W23.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626515398","title":"LB Pharmaceuticals Announces Presentation at 25th Annual Needham Virtual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2626515398","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626515398?lang=en_us&edition=fundamental","pubTime":"2026-04-10 04:05","pubTimestamp":1775765100,"startTime":"0","endTime":"0","summary":"NEW YORK, April  09, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schiz","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/09/3271401/0/en/LB-Pharmaceuticals-Announces-Presentation-at-25th-Annual-Needham-Virtual-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4233","BK4581","BK4137","BK4588","LB","BK4213","LU0029874061.USD","LABU","BK4585","XLV","BK4007","XBI","HCSG","LU0128526141.USD","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625601308","title":"LB Pharmaceuticals files to sell 4.78M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2625601308","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625601308?lang=en_us&edition=fundamental","pubTime":"2026-04-07 04:13","pubTimestamp":1775506382,"startTime":"0","endTime":"0","summary":"16:06 EDT LB Pharmaceuticals (LBRX) files to sell 4.78M shares of common stock for holders Published first on TheFly – the ultimate source for real...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-files-to-sell-4-78m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-files-to-sell-4-78m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4213","BK4007","BK4233","LB","LBRX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":65,"code":"91000000","status":"200"}]}}